Holen Sie sich die Stockscreener-App
1.13
0.00%
0.00
Handel nachbörslich:
1.07
-0.06
-5.31%
Schlusskurs vom Vortag:
$1.13
Offen:
$1.15
24-Stunden-Volumen:
1.78M
Relative Volume:
7.12
Marktkapitalisierung:
$94.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.60%
1M Leistung:
-36.87%
6M Leistung:
+29.07%
1J Leistung:
+15.79%
1-Tages-Spanne:
$1.07
$1.2076
1-Wochen-Bereich:
$1.07
$1.36
52-Wochen-Spanne:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Firmenname
Citius Oncology Inc
Sektor
Telefon
(908) 967-6677
Adresse
11 COMMERCE DRIVE, CRANFORD
Vergleichen Sie CTOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.13 | 94.37M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2024-11-27 | Eingeleitet | Maxim Group | Buy |
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
Citius Oncology to advance LYMPHIR launch with AI technology By Investing.com - Investing.com Nigeria
Citius Oncology stock soars on expanded AI collaboration for LYMPHIR launch - Investing.com
Citius Oncology to advance LYMPHIR launch with AI technology - Investing.com India
Citius Oncology (Nasdaq: CTOR) taps Verix AI to support Q4 2025 LYMPHIR CTCL launch - Stock Titan
Is Citius Oncology Inc. stock attractive after correctionQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Citius Oncology Inc.’s volatility index tracking explainedWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Will Citius Oncology Inc. stock rally after Fed decisionsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Will Citius Oncology Inc. stock keep outperforming rivals2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - newser.com
Using Bollinger Bands to evaluate Citius Oncology Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - newser.com
How Citius Oncology Inc. stock compares to market leadersPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Is Citius Oncology Inc. stock supported by innovation pipeline2025 Price Momentum & Short-Term Trading Alerts - newser.com
Will Citius Oncology Inc. stock deliver strong dividend growth2025 Volatility Report & Community Shared Stock Ideas - newser.com
How Citius Oncology Inc. stock reacts to oil pricesWeekly Volume Report & Weekly High Conviction Ideas - newser.com
What the charts say about Citius Oncology Inc. today2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Why Citius Oncology Inc. stock is a value investor pickJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
What data driven models say about Citius Oncology Inc.’s futureJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
News impact scoring models applied to Citius Oncology Inc.Earnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences - Lelezard
Finanzdaten der Citius Oncology Inc-Aktie (CTOR)
Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):